The Asia-Pacific region is rapidly emerging as a hub for cell and gene therapy (CGT). With growing investments, advanced cGMP manufacturing, and expanding clinical trials, the region offers significant opportunities for innovation, personalized medicine, and transformative therapies in cancer, rare diseases, and regenerative medicine. https://www.newsengineers.com/cell-and-gene-therapy-asia-pacific-opportunities/